Sector Moderna, Inc.

Aandelen

MRNA

US60770K1079

Farmaceutische producten

Beurs gesloten - Nasdaq 22:00:00 05-12-2025 Nabeurs 01:55:16
27,70 USD +8,67% Intraday-grafiek van Moderna, Inc. 27,58 -0,45%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+8,67%+6,62%+17,57%+10,18%-33,38%-35,49%-84,26%-81,84% - 10,82 mld.
-0,61%-7,92%+11,51%+25,29%+0,85%-6,45%-4,91%+45,87%+28,59% 73,7 mld.
-0,81%-1,18%+4,40%-12,02%-34,62%-34,65%-38,63%-37,34%+87,44% 58,94 mld.
+3,17%+2,91%+14,21%+19,62%+28,77%+33,60%+245,77%+179,09%+199,27% 54,7 mld.
-2,32%+64,10%+64,10%+64,10%+64,10%+64,10%+64,10%+64,10% - 51,57 mld.
-0,37%-0,43%+18,16%+28,88%+18,56%+13,84%-38,07%-26,26%-36,26% 26,6 mld.
-1,66%-2,23%+4,49%-10,77%+151,37%+144,36%+231,53%+59,86% - 20,25 mld.
+2,05%-1,86%-3,01%+18,33%+48,43%+36,84%+21,93%+23,31%-6,04% 20,13 mld.
-12,04%-14,35%-13,71%-4,00%+47,50%+46,78%+1.041,25%+390,27%+7.887,36% 16,58 mld.
-1,50%+2,26%+17,52%+37,95%+168,37%+176,22%+703,05%+41,10% - 14,19 mld.
-0,04%-.--%-.--%-.--%+57,89%+56,82%+143,08%+423,92%+131,76% 14,02 mld.
-0,12%+1,12%+4,83%+24,04%+7,94%+10,80%+61,99%+105,40%+157,01% 12,54 mld.
+0,13%-0,10%+2,62%+42,24%+146,32%+94,22%+540,70%+120,26% - 10,79 mld.
-0,78%-4,52%+1,14%-7,56%-18,76%-19,29%-48,42%-32,92%-45,57% 10,26 mld.
-0,47%-5,37%-2,38%-17,05%+386,51%+378,64%+274,90%+294,40%+171,38% 9,09 mld.
-0,96%+7,74%+22,64%+40,70%+234,97%+236,31%+1.032,99%+920,73%+534,69% 8,7 mld.
+0,37%-2,77%-15,31%-18,49%-33,74%-38,80%-56,34%-26,61% - 8,35 mld.
+0,19%+2,09%+0,05%-12,60%+17,51%+23,05%-2,27%-54,56%-51,16% 7,59 mld.
+0,80%-1,50%+9,97%+19,21%+76,36%+51,72%+93,07%+86,39%+1.635,12% 7,52 mld.
+0,70%-2,24%-4,78%-8,43%-23,57%-30,74%-64,89%-78,36%+68,44% 6,81 mld.
Gemiddelde -0,74%-1,73%+7,70%+11,98%+65,57%+60,10%+205,83%+120,84%+768,72% 22,16 mld.
Gewogen gemiddelde per kap. -0,62%-2,06%+13,78%+17,49%+41,46%+37,98%+144,27%+89,87%+518,84%
Biofarmaceutica
  1. Beurs
  2. Aandelen
  3. Koers MRNA
  4. Sector Moderna, Inc.